Follow
Kaila Bennett
Kaila Bennett
Senior Scientist, BPGBio
No verified email
Title
Cited by
Cited by
Year
Mucosal vaccine design and delivery
KA Woodrow, KM Bennett, DD Lo
Annual review of biomedical engineering 14, 17-46, 2012
2402012
Epithelial microvilli establish an electrostatic barrier to microbial adhesion
KM Bennett, SL Walker, DD Lo
Infection and immunity 82 (7), 2860-2871, 2014
592014
Intranasal M cell uptake of nanoparticles is independently influenced by targeting ligands and buffer ionic strength
TE Rajapaksa, KM Bennett, M Hamer, C Lytle, VGJ Rodgers, DD Lo
Journal of biological chemistry 285 (31), 23739-23746, 2010
582010
Induction of colonic M cells during intestinal inflammation
KM Bennett, EA Parnell, C Sanscartier, S Parks, G Chen, MG Nair, DD Lo
The American journal of pathology 186 (5), 1166-1179, 2016
482016
Let’s tie the knot: marriage of complement and adaptive immunity in pathogen evasion, for better or worse
KM Bennett, SHM Rooijakkers, RD Gorham Jr
Frontiers in Microbiology 8, 89, 2017
402017
Hybrid flagellin as a T cell independent vaccine scaffold
KM Bennett, RD Gorham, V Gusti, L Trinh, D Morikis, DD Lo
BMC biotechnology 15, 1-12, 2015
292015
CD 137 signaling enhances tight junction resistance in intestinal epithelial cells
V Gusti, KM Bennett, DD Lo
Physiological Reports 2 (8), e12090, 2014
122014
Hybrid flagellin as at cell independent vaccine scaffold
DD Lo, KM Bennett
US Patent App. 15/737,058, 2018
2018
Protection of Epithelial Barrier Function Against Bacterial Infection by the IBD Candidate Gene PTPN2
M Krishnan, R Alvarez, K Bennett, M Nair, D Lo, D McCole
The FASEB Journal 29, 853.5, 2015
2015
Breaking Down the Barrier: Novel Insights Into the Role of Intestinal Microvilli, M cells, and Exploiting" Innate" B Cells as Therapeutic Targets
KM Bennett
University of California, Riverside, 2014
2014
The system can't perform the operation now. Try again later.
Articles 1–10